l-Asparagine depletion levels and l-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment

By Tsurusawa Masahito   Chin Motoaki   Iwai Asayuki   Nomura Keiko   Maeba Hideaki   Taga Takashi   Higa Takeshi   Kuno Tomoko   Hori Toshinori   Muto Akiko   Yamagata Miyo  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 3, 2004-03 ,pp. : 204-208

Springer Publishing Company

Access to resources Recommend Favorite

Expression of asparagine synthetase predicts in vitro response to l-asparaginase in canine lymphoid cell lines

By Smallwood Tangi L.   Small George W.   Suter Steven E.   Richards Kristy L.  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1357-1365

Informa Healthcare

Access to resources Recommend Favorite

Use of PEG-asparaginase in the treatment of patients with solid tumors

By Pinheiro João   Lanvers Claudia   Boos Joachim  

Cancer Chemotherapy and Pharmacology, Vol. 48, Iss. 5, 2001-11 ,pp. : 421-422

Springer Publishing Company

Access to resources Recommend Favorite

Expanding Targets for a Metabolic Therapy of Cancer: L-Asparaginase

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 1, 2012-01 ,pp. : 4-13

Bentham Science Publishers

Access to resources Recommend Favorite

PEG-asparaginase (Oncaspar) 2500 U/m BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols

By Müller Hans-Joachim   Beier Rita   da Palma João   Lanvers Claudia   Ahlke Elvira   von Schütz Volker   Gunkel Martin   Horn Alexander   Schrappe Martin   Henze Günter   Kranz Karen   Boos Joachim  

Cancer Chemotherapy and Pharmacology, Vol. 49, Iss. 2, 2002-02 ,pp. : 149-154

Springer Publishing Company

Access to resources Recommend Favorite